Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Carraghenates Cream vs Mayinglong Musk Hemorrhoid Ointment in Hemorrhoids
NCT01881282Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carrageenan + titanium dioxide + zinc oxide in Hemorrhoids (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Pain Acting Time, Pain Intensity Score at Day 7 and 4 more. Started Dec 2006; status: completed.
02
Drugs
carrageenan + titanium dioxide + zinc oxide
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT01881282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01881282.